NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly

RecruitingN/A

Sponsor: Camurus AB

Conditions: Acromegaly

Interventions: Octreotide subcutaneous depot

Countries: Germany, United Kingdom

The purpose of this study is to collect long-term (up to two years) safety and effectiveness of octreotide subcutaneous depot in patients with acromegaly in the real-world setting.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Have started or will be starting treatment with octreotide SC depot for acromegaly

Exclusion Criteria:

* Have started or will be starting treatment with octreotide SC depot for other conditions not related to acromegaly
* Currently taking part in an interventional clinical trial or is still within a 30-day washout period from the end of taking part in an interventional clinical trial.

Locations (6)

Aachen, Germany
Leipzig, Germany
Magdeburg, Germany
München, Germany
Würzburg, Germany
Leeds, United Kingdom